Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

Article  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research Network, Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, et al. Genomic and epigenomic landscapes of Adult De Novo acute myeloid leukemia. N Engl J Med. 2013;368:2059–74.

Article  Google Scholar 

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

Article  PubMed  PubMed Central  Google Scholar 

Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36:1703–19.

Article  PubMed  PubMed Central  Google Scholar 

Bullinger L, Döhner K, Döhner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35:934–46.

Article  PubMed  Google Scholar 

Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, Disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell. 2010;18:553–67.

Article  PubMed  PubMed Central  Google Scholar 

De Boer B, Sheveleva S, Apelt K, Vellenga E, Mulder AB, Huls G, et al. The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis. Haematologica. 2020;106:3067–78.

Article  PubMed Central  Google Scholar 

Caiado F, Kovtonyuk LV, Gonullu NG, Fullin J, Boettcher S, Manz MG. Aging drives Tet2+/− clonal hematopoiesis via IL-1 signaling. Blood. 2023;141:886–903.

Article  PubMed  Google Scholar 

Carey A, Edwards DK, Eide CA, Newell L, Traer E, Medeiros BC, et al. Identification of Interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia. Cell Rep. 2017;18:3204–18.

Article  PubMed  PubMed Central  Google Scholar 

Steinhäuser S, Silva P, Lenk L, Beder T, Hartmann A, Hänzelmann S, et al. Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML). Leukemia. 2022;37:134–42.

Article  PubMed  PubMed Central  Google Scholar 

Kristinsson SY, Björkholm M, Hultcrantz M, Derolf ÅR, Landgren O, Goldin LR. Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol. 2011;29:2897–903.

Article  PubMed  PubMed Central  Google Scholar 

Friedrich M, Sankowski R, Bunse L, Kilian M, Green E, Ramallo Guevara C, et al. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas. Nat Cancer. 2021;2:723–40.

Article  PubMed  Google Scholar 

Burns SS, Kumar R, Pasupuleti SK, So K, Zhang C, Kapur R. Il-1r1 drives leukemogenesis induced by Tet2 loss. Leukemia. 2022;36:2531–4.

Article  PubMed  PubMed Central  Google Scholar 

Stratmann S, Yones SA, Garbulowski M, Sun J, Skaftason A, Mayrhofer M, et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Adv. 2022;6:152–64.

Article  PubMed  PubMed Central  Google Scholar 

Rodriguez-Sevilla JJ, Adema V, Chien KS, Loghavi S, Ma F, Yang H, et al. The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial. Nat Commun. 2024;15:9840.

Article  PubMed  PubMed Central  Google Scholar